Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top 10 Correlated Stocks

CWBR


In the News

06:21 30 Sep 2022 CWBR

7 Nasdaq Stocks to Sell Before They Die

As is typical of a bear market, the Nasdaq has led the other major indices lower over the past year. The tech-heavy index is down 28% over the past 12 months compared with a 17% decline in the S&P 500.

08:35 30 Sep 2022 CWBR

CohBar (CWBR) Stock: 1-For-30 Reverse Split Goes Into Effect

A 1-for-30 reverse split of CohBar (CWBR) stock has gone into effect today. These are the details.

09:00 30 Sep 2022 CWBR

CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference

MENLO PARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company exploiting the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, announced today that its Chief Executive Officer, Dr. Joseph Sarret, will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference, being held September 12 - 14, 2022.

08:11 30 Sep 2022 CWBR

CohBar, Inc. (CWBR) CEO Joe Sarret on Q2 2022 Results - Earnings Call Transcript

CohBar, Inc. (NASDAQ:CWBR ) Q2 2022 Earnings Conference Call August 15, 2022 5:00 PM ET Company Participants Jordyn Tarazi - Director of IR Joe Sarret - CEO Jeff Biunno - CFO Nick Vlahakis - Acting CMO Kent Grindstaff - SVP, Research Conference Call Participants Kumar Raja - Brookline Capital Markets Operator Good afternoon. My name is Ryan, and I will be your conference operator for today.

09:00 30 Sep 2022 CWBR

CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022

Company to host conference call and webcast at 5:00 p.m. ET Company to host conference call and webcast at 5:00 p.m. ET

04:02 30 Sep 2022 CWBR

CohBar to Present at the H.C. Wainwright Global Investment Conference

MENLO PARK, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, announced today its virtual participation in the 2022 H.C. Wainwright Global Investment Conference.

09:20 30 Sep 2022 CWBR

CohBar Inc. (CWBR) CEO Joe Sarret on Q1 2022 Results - Earnings Call Transcript

CohBar Inc. (NASDAQ:CWBR ) Q1 2022 Results Conference Call May 16, 2022 5:00 PM ET Company Participants Joe Sarret - CEO Jeff Biunno - CFO Nick Vlahakis - Acting CMO Kent Grindstaff - SVP, Research Conference Call Participants Kristen Kluska - Cantor Fitzgerald Kumar Raja - Brookline Capital Markets Operator Good afternoon. My name is John, and I will be your conference operator today.

09:00 30 Sep 2022 CWBR

CohBar to Announce 2022 First Quarter Financial Results and Provide Business Update on May 16, 2022

Company to host conference call and webcast at 5:00 p.m. ET Company to host conference call and webcast at 5:00 p.m. ET

10:44 30 Sep 2022 CWBR

CohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call Transcript

CohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call Transcript

09:00 30 Sep 2022 CWBR

CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022

Company to host conference call and webcast at 5:00 p.m. ET Company to host conference call and webcast at 5:00 p.m. ET

Financial details

Company Rating
Neutral
Market Cap
8.57M
Income
-24.88M
Revenue
0
Book val./share
7.14
Cash/share
6.93
Dividend
-
Dividend %
-
Employees
9
Optionable
No
Shortable
Yes
Earnings
14 Nov 2022
P/E
-0.35
Forward P/E
-
PEG
0.78
P/S
-
P/B
0.42
P/C
0.43
P/FCF
-0.72
Quick Ratio
65.12
Current Ratio
68.58
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-9.55
EPS next Y
-
EPS next Q
-
EPS this Y
-4.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-16.7%
-
-
-
-
SMA20
-26.64%
SMA50
-36.97%
SMA100
-48.78%
Inst Own
10.25%
Inst Trans
-1.55%
ROA
-116%
ROE
-120%
ROC
-0.45%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
2.9M
Shs Float
2.48M
-
-
-
-
Target Price
-
52W Range
2.809-32.7
52W High
-90.72%
52W Low
+48.5%
RSI
24.94
Rel Volume
1.64
Avg Volume
26.66K
Volume
43.61K
Perf Week
-29.79%
Perf Month
-43.43%
Perf Quarter
-64.89%
Perf Half Y
-69.25%
-
-
-
-
Beta
2.22932
-
-
Volatility
0.58%, 0.74%
Prev Close
-1.98%
Price
2.97
Change
5.32%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
00000
Net income per share
-7.87-11.42-9.14-10-9.51
Operating cash flow per share
-6.11-7.37-7.08-6.01-8.88
Free cash flow per share
-6.13-7.67-7.19-6.03-8.88
Cash per share
6.7716.138.812.9216.13
Book value per share
6.113.065.711.3615.74
Tangible book value per share
6.0813.055.6911.3515.73
Share holders equity per share
6.113.065.711.3615.74
Interest debt per share
02.532.880.930.25
Market cap
8.01M4.41M3.44M2.81M520.69K
Enterprise value
5.18M1.61M-5.77M618.57K-4.11M
P/E ratio
-0.81-0.28-0.26-0.17-0.03
Price to sales ratio
00000
POCF ratio
-1.05-0.44-0.34-0.29-0.04
PFCF ratio
-1.05-0.42-0.34-0.29-0.04
P/B Ratio
1.050.250.420.150.02
PTB ratio
1.050.250.420.150.02
EV to sales
00000
Enterprise value over EBITDA
-0.53-0.110.47-0.04-29.13
EV to operating cash flow
-0.68-0.160.57-0.060.28
EV to free cash flow
-0.68-0.150.56-0.060.28
Earnings yield
-1.23-3.56-3.79-5.78-29.72
Free cash flow yield
-0.96-2.39-2.98-3.48-27.76
Debt to equity
00.160.410.020
Debt to assets
0.140.220.40.160.06
Net debt to EBITDA
0.290.180.760.14-32.83
Current ratio
6.9210.386.346.9815.96
Interest coverage
-2.7K-27.52-16.73-16.18-384.17
Income quality
0.780.650.770.60.93
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00.040.0100
Capex to revenue
00000
Capex to depreciation
-0.46-5.35-1.01-0.17-0.05
Stock based compensation to revenue
00000
Graham number
32.8657.9434.2450.5558.03
ROIC
-1.29-0.73-1.09-0.7-0.6
Return on tangible assets
-1.11-0.68-0.97-0.74-0.57
Graham Net
5.7712.445.0210.8115.17
Working capital
7.37M20.28M10.89M18.36M25.26M
Tangible asset value
7.6M17.94M8.12M18.47M25.59M
Net current asset value
7.37M17.36M7.53M18.01M25.26M
Invested capital
00.160.410.040.01
Average receivables
00000
Average payables
609.81K935.17K586.19K727.6K549.8K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-1.29-0.87-1.6-0.88-0.6
Capex per share
-0.02-0.31-0.1-0.020

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
00000
Net income per share
-2.53-1.61-5.87-1.13-0.94
Operating cash flow per share
-2.1-1.53-1.03-0.87-1.18
Free cash flow per share
-2.1-1.53-1.03-0.87-1.18
Cash per share
6.77.059.968.146.93
Book value per share
5.896.519.727.967.14
Tangible book value per share
5.896.519.717.967.14
Share holders equity per share
5.896.519.727.967.14
Interest debt per share
0.180.180.1500
Market cap
2.89M2.04M922.4K907.74K550.88K
Enterprise value
1.64M-6.77M-3.7M-656.25K-2.33M
P/E ratio
-0.14-0.15-0.01-0.07-0.05
Price to sales ratio
00000
POCF ratio
-0.67-0.63-0.34-0.36-0.16
PFCF ratio
-0.67-0.63-0.34-0.36-0.16
P/B Ratio
0.240.150.040.040.03
PTB ratio
0.240.150.040.040.03
EV to sales
00000
Enterprise value over EBITDA
-0.322.01-111.620.2-72.18
EV to operating cash flow
-0.382.071.360.260.68
EV to free cash flow
-0.382.071.360.260.68
Earnings yield
-1.81-1.67-16.78-3.59-4.95
Free cash flow yield
-1.5-1.6-2.94-2.77-6.19
Debt to equity
00000
Debt to assets
0.210.140.060.050.03
Net debt to EBITDA
0.242.61-139.420.49-89.26
Current ratio
4.756.7715.9619.5368.58
Interest coverage
-243.93-286.14-69.35-308.260
Income quality
0.830.950.180.771.25
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
0-0.07000
Stock based compensation to revenue
00000
Graham number
18.3315.3435.8314.2112.29
ROIC
-0.43-0.25-0.11-0.140
Return on tangible assets
-0.34-0.21-0.57-0.13-0.13
Graham Net
5.185.959.377.726.68
Working capital
11.74M13.49M25.26M22.68M20.86M
Tangible asset value
0025.59M020.69M
Net current asset value
11.74M13.49M25.26M22.68M20.42M
Invested capital
0.030.030.0100
Average receivables
00000
Average payables
1.25M973.81K506.34K640.69K474.65K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.43-0.25-0.6-0.14-0.13
Capex per share
00000

Frequently Asked Questions

What is CohBar, Inc. stock symbol ?

CohBar, Inc. is a US stock , located in Menlo park of California and trading under the symbol CWBR

What is CohBar, Inc. stock quote today ?

CohBar, Inc. stock price is $2.97 today.

Is CohBar, Inc. stock public?

Yes, CohBar, Inc. is a publicly traded company.

Something similar

Same Sector
Top Correlated Stocks
Similar Market Cap